Paving the way to improve therapy for Myeloproliferative Neoplasms Comment

被引：3
|
作者：
Bywater, Megan [1 ,2 ,3 ]
Lane, Steven W. [1 ,2 ,3 ]
机构：
[1] QIMR Berghofer MRI, Canc Program, Brisbane, Qld 4006, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia
[3] Royal Brisbane & Womens Hosp, Canc Care Serv, Brisbane, Qld 4029, Australia
来源：
NATURE COMMUNICATIONS | 2022年 / 13卷 / 01期
关键词：
HEMATOPOIETIC STEM; MURINE MODEL; CELLS; ALPHA;
D O I：
10.1038/s41467-022-32694-2
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Long-acting IFN alpha induces durable molecular responses in myeloproliferative neoplasms. Emerging studies, including Saleiro et al. recently published in Nature Communications, have identified promising candidates that may synergise with IFN alpha by targeting stem cell function or feedback loops that mediate treatment resistance.
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Paving the way to improve therapy for Myeloproliferative Neoplasms
    Megan Bywater
    Steven W. Lane
    Nature Communications, 13
  • [2] Splicing Anomalies in Myeloproliferative Neoplasms: Paving the Way for New Therapeutic Venues
    Hautin, Marie
    Mornet, Clelia
    Chauveau, Aurelie
    Bernard, Delphine G.
    Corcos, Laurent
    Lippert, Eric
    CANCERS, 2020, 12 (08) : 1 - 22
  • [3] Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms
    Alvarez-Larran, Alberto
    Besses, Carlos
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 319 - 323
  • [4] Molecular pathogenesis and therapy of myeloproliferative neoplasms
    Koppikar, Priya
    Abdel-Wahab, Omar
    Marubayashi, Sachie
    Kilpivaara, Outi
    Kucine, Nicole
    Levine, Ross L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [5] Antiplatelet Therapy in the Management of Myeloproliferative Neoplasms
    Alberto Alvarez-Larrán
    Carlos Besses
    Current Hematologic Malignancy Reports, 2014, 9 : 319 - 323
  • [6] Paving the Way for Improved Antiplatelet Therapy
    Grove, Erik Lerkevang
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (33) : 5195 - 5196
  • [7] Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
    Vannucchi, Alessandro M.
    Guglielmelli, Paola
    Rambaldi, Alessandro
    Bogani, Costanza
    Barbui, Tiziano
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8A) : 1437 - 1450
  • [8] Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms
    Charles Elliott Foucar
    Brady Lee Stein
    Current Hematologic Malignancy Reports, 2017, 12 : 406 - 414
  • [9] Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
    De Stefano, Valerio
    Finazzi, Guido
    Barbui, Tiziano
    BLOOD CANCER JOURNAL, 2018, 8
  • [10] Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms
    Valerio De Stefano
    Guido Finazzi
    Tiziano Barbui
    Blood Cancer Journal, 8
12345